- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1411EUR$1,600USD£1,240GBP
€1764EUR$2,000USD£1,550GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1411EUR$1,600USD£1,240GBP
€1764EUR$2,000USD£1,550GBP
- Report
- January 2025
- 194 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- January 2025
- 160 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- May 2025
- 115 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- May 2025
- 125 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- May 2025
- 141 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- May 2025
- 136 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- December 2025
- 272 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 473 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 381 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 462 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 154 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 383 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 180 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 196 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- May 2025
- 166 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- June 2025
- 347 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 200 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- October 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups.
The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products.
Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more